Ex parte KYLE et al. - Page 11




             Appeal No. 1997-0100                                                                                     
             Application 08/167,051                                                                                   


             J is Arg;                                                                                                
             Cn is a hydroxyl group;                                                                                  
                    and pharmaceutically acceptable salts thereof.                                                    
                    42.    A peptide having the formula:                                                              
             N-A-B-C-D-E-F-G-H-I-J-Cn, wherein                                                                        
             N is hydrogen;                                                                                           
             A is D-Arg;                                                                                              
             B is Arg;                                                                                                
             C and D are independently selected from the group consisting of Pro and 4Hyp;                            
             E is Gly;                                                                                                
             F is selected from the group consisting of Phe, Leu, and Thi;                                            
             G is a direct bond or is Ser;                                                                            
             H is a compound of the D-configuration selected from the [sic group] consisting of D-Phe                 
             and D-Tic;                                                                                               
             I is selected from the group consisting of Oic, Aoc, Tic and compounds of the formula:                   











                                                          2                                                           





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  Next 

Last modified: November 3, 2007